Clinical Trial Update: Mometasone Furoate Cream Reduces Acute Radiation Dermatitis in Head and Neck Squamous Cell Carcinomas' Patients [Phase 4]

View source ↗

Summary

Phase 4 trial suggests that topical mometasone furoate cream reduces acute radiation dermatitis in patients with head and neck squamous cell carcinoma undergoin…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Squamous Cell Carcinoma

Drugs mentioned

• Mometasone Furoate Cream (mometasone furoate)

Snippet

Sponsor: Yao Liao | Conditions: Early Radiation Dermatitis | Phase 4 | Status: UNKNOWN